Published in Nucleic Acids Res on August 14, 2013
Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum. PLoS One (2014) 1.02
MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease. Front Physiol (2013) 1.00
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration. Hum Mol Genet (2015) 0.95
Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice. Sci Rep (2015) 0.94
Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma. Front Aging Neurosci (2014) 0.88
MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One (2014) 0.85
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. Hum Mol Genet (2015) 0.84
The role of epigenetic-related codes in neurocomputation: dynamic hardware in the brain. Philos Trans R Soc Lond B Biol Sci (2014) 0.81
Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics. Sci Rep (2015) 0.81
Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy. Environ Health Prev Med (2014) 0.81
Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs. Sci Rep (2015) 0.80
Frontier impact of microRNAs in skeletal muscle research: a future perspective. Front Physiol (2015) 0.80
Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy. Mol Ther Nucleic Acids (2016) 0.79
What do mouse models of muscular dystrophy tell us about the DAPC and its components? Int J Exp Pathol (2014) 0.79
Detection and quantification of extracellular microRNAs in murine biofluids. Biol Proced Online (2014) 0.79
Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases. J Neuromuscul Dis (2016) 0.78
Acute responses of circulating microRNAs to low-volume sprint interval cycling. Front Physiol (2015) 0.76
Movement of regulatory RNA between animal cells. Genesis (2015) 0.76
Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation. Hum Mol Genet (2016) 0.75
Circulating Biomarkers for Duchenne Muscular Dystrophy. J Neuromuscul Dis (2015) 0.75
Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies. Rare Dis (2014) 0.75
MicroRNA deep sequencing in two adult stem cell populations identifies miR-501 as a novel regulator of myosin heavy chain during muscle regeneration. Development (2016) 0.75
Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx Mice. PLoS One (2016) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res (2004) 25.98
Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27
Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett (2003) 18.34
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet (2005) 17.07
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol (2011) 9.68
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res (2009) 9.64
Serum microRNAs are promising novel biomarkers. PLoS One (2008) 8.69
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 8.21
Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem (2010) 8.09
Myogenic satellite cells: physiology to molecular biology. J Appl Physiol (1985) (2001) 6.27
A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol (2009) 6.25
Characterization of extracellular circulating microRNA. Nucleic Acids Res (2011) 6.24
Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med (2011) 5.91
Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol (2006) 5.78
Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77
Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res (2010) 5.29
Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol (2005) 5.19
Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal (2009) 4.73
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res (2011) 4.55
Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem (2002) 3.72
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet (2008) 2.27
Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods (2012) 2.25
Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J (2009) 2.22
Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation (2012) 2.14
Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (1986) 1.97
The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol (1988) 1.96
Targeting RNA to treat neuromuscular disease. Nat Rev Drug Discov (2011) 1.89
microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest (2012) 1.84
miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med (2011) 1.80
MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct Funct (2008) 1.76
Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles (2013) 1.57
Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther Nucleic Acids (2012) 1.53
Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One (2011) 1.52
Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis. Mol Cell (2012) 1.46
Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med (2010) 1.44
miRandola: extracellular circulating microRNAs database. PLoS One (2012) 1.43
Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment. Mol Ther Nucleic Acids (2012) 1.41
Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol (2012) 1.38
Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression. Neuropathol Appl Neurobiol (2009) 1.36
MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J Biol Chem (2011) 1.36
MicroRNA identity and abundance in porcine skeletal muscles determined by deep sequencing. Anim Genet (2009) 1.26
Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges. Curr Gene Ther (2012) 1.21
Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int J Exp Pathol (2003) 1.20
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping. Hum Mol Genet (2012) 1.10
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol (2011) 9.68
Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell (2005) 7.15
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol (2009) 5.35
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (2011) 4.78
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis (2011) 2.32
Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep (2010) 2.31
Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet (2012) 2.13
A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells (2007) 2.03
Targeting RNA to treat neuromuscular disease. Nat Rev Drug Discov (2011) 1.89
Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med (2013) 1.89
New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood (2010) 1.82
Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles (2012) 1.81
Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res (2011) 1.76
Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc (2012) 1.70
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum Mol Genet (2008) 1.69
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript. Mol Ther (2007) 1.67
Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics (2012) 1.60
Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries. PLoS Negl Trop Dis (2011) 1.60
Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther Nucleic Acids (2012) 1.53
Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. Nucleic Acids Res (2008) 1.52
Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One (2011) 1.52
Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol (2008) 1.52
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy. J Gene Med (2002) 1.48
Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment. Mol Ther Nucleic Acids (2012) 1.41
Re: preventing the incurable: Asian rabies experts advocate rabies control. Vaccine (2006) 1.41
Modulating the expression of disease genes with RNA-based therapy. PLoS Genet (2007) 1.38
Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg (2002) 1.37
Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles. Dev Biol (2009) 1.37
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice. Hum Mol Genet (2009) 1.34
Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci (2006) 1.34
Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials. Neuromuscul Disord (2010) 1.34
Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells (2005) 1.34
Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice. PLoS One (2011) 1.31
Genetic therapies for RNA mis-splicing diseases. Trends Genet (2011) 1.31
Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol Ther (2011) 1.30
A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol (2008) 1.27
Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine (2012) 1.27
Release of reactive oxygen and nitrogen species from contracting skeletal muscle cells. Free Radic Biol Med (2004) 1.24
Are human and mouse satellite cells really the same? J Histochem Cytochem (2010) 1.21
Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release (2013) 1.21
Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release (2011) 1.21
Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord (2002) 1.21
Localization of double-stranded small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2. Mol Biol Cell (2008) 1.20
The biogenesis and characterization of mammalian microRNAs of mirtron origin. Nucleic Acids Res (2011) 1.20
Novel RNA-based strategies for therapeutic gene silencing. Mol Ther (2010) 1.20
Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum Mol Genet (2010) 1.19
Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells (2006) 1.18
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain (2011) 1.17
Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev (2012) 1.17
Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy. PLoS One (2013) 1.16
Localisation of proteins of iron metabolism in the human placenta and liver. Br J Haematol (2006) 1.16
Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation. PLoS One (2009) 1.15
DNA cage delivery to mammalian cells. ACS Nano (2011) 1.13
Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther (2012) 1.10
Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS One (2013) 1.10
Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells (2006) 1.09
The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One (2011) 1.07
An in-vitro model for stromal invasion during implantation of the human blastocyst. Hum Reprod (2003) 1.05
A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration. Neuromuscul Disord (2004) 1.05
Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol Cell Proteomics (2013) 1.05
Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol (2008) 1.05
Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine (2009) 1.02
RNA splicing: disease and therapy. Brief Funct Genomics (2011) 1.02
Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci Res (2011) 1.00
Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements. Dev Biol (2004) 1.00
Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated. Stem Cells (2012) 0.98
Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. Mol Ther (2010) 0.98
Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype. PLoS One (2009) 0.98
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation. Nucleic Acids Res (2011) 0.97
The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation. J Neuroinflammation (2011) 0.97
The CRTC1-SIK1 pathway regulates entrainment of the circadian clock. Cell (2013) 0.97
Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. Hum Mol Genet (2009) 0.97
Recent progress in satellite cell/myoblast engraftment -- relevance for therapy. FEBS J (2013) 0.96
Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice. Hum Mol Genet (2013) 0.95
Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs. Nucleic Acid Ther (2012) 0.95
Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. J Cell Sci (2004) 0.95
Splicing therapy for neuromuscular disease. Mol Cell Neurosci (2013) 0.95
Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA. Mol Ther Nucleic Acids (2012) 0.95
The human desmin locus: gene organization and LCR-mediated transcriptional control. Genomics (2006) 0.95
Relationship between diffusion tensor imaging and brain morphology in patients with myotonic dystrophy. Neurosci Lett (2006) 0.94
The origins and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol (2011) 0.94
Activin and follistatin in female reproduction. Mol Cell Endocrinol (2004) 0.93
In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy. J Gene Med (2010) 0.93
The global availability of rabies immune globulin and rabies vaccine in clinics providing direct care to travelers. J Travel Med (2013) 0.92
Stem cells to treat muscular dystrophies - where are we? Neuromuscul Disord (2010) 0.92
Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient. PLoS One (2010) 0.92
Mirtrons, an emerging class of atypical miRNA. Wiley Interdiscip Rev RNA (2012) 0.92
Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse. Stem Cells (2012) 0.92
System y+ arginine transport and NO production in peripheral blood mononuclear cells in pregnancy and preeclampsia. Hypertension (2005) 0.91